Navigation Links
Phase 3 Data Show New Anti-TNF, Golimumab, Significantly Improved Arthritis, Skin and Nail Manifestations in Patients with Psoriatic Arthritis
Date:11/7/2007

golimumab 100 mg, respectively, achieved PASI 75 at week 14, compared with 3 percent of patients receiving placebo (P < 0.001). At week 24, PASI 75 responses improved to 56 percent (golimumab 50 mg) and 66 percent (golimumab 100 mg), compared with 1 percent of placebo patients (P < 0.001). In additional analyses, patients receiving golimumab 50 mg and golimumab 100 also experienced improvements in nail psoriasis as measured by NAPSI and these improvements were sustained over time.

"These Phase 3 data show that once monthly subcutaneous administrations of golimumab 50 mg and golimumab 100 mg significantly improved articular and psoriatic manifestations in patients with psoriatic arthritis," said Jerome A. Boscia, MD, senior vice president, Clinical Research and Development, Centocor, Inc. "We are encouraged by these results and believe golimumab holds great promise as a new anti-TNF-alpha therapy for physicians and patients in need of additional therapeutic options."

Disease Activity and Physical Function Improvements

The majority of golimumab-treated patients in the study were classified as good or moderate responders as measured by the Disease Activity Score 28 (DAS28), which measures tender and swollen joints and overall disease activity including measurement of serum C-reactive protein (CRP) levels. After 14 weeks of treatment, 66 percent of patients receiving golimumab 50 mg were DAS28 responders, as were 67 percent of patients receiving the 100 mg dose, compared with 24 percent of patients receiving placebo (P < 0.001). At week 24, 64 percent and 78 percent of patients receiving golimumab 50 mg and 100 mg, respectively, were DAS28 responders, compared with 24 percent of patients receiving placebo (P < 0.001).

Patients receiving golimumab in the study also experienced significant improvements in physical function, as measured by the Health Assessment Questionnaire (HAQ). At week 14, patients receiving golimumab 50 mg experienced a mean i
'/>"/>

SOURCE Centocor Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
3. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
4. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
7. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
10. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
11. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/17/2014)... 17, 2014 HemoShear and Children,s National Health ... Partnering for Cures conference to be held November ... Marshall Summar , MD, Division Chief of Genetics and ... President of R&D and Co-founder of HemoShear, will introduce a ... in less time and with higher success rates. ...
(Date:11/17/2014)... Corp. (CTI) (NASDAQ and MTA: CTIC) announced today management will ... 2014 Global Healthcare Conference Wednesday, November 19 at 9:20 ... . Piper Jaffray 26 th ... EST, New York, NY . ... replay after the presentation. The webcast can be accessed at ...
(Date:11/16/2014)... -- Volgens de maandag gepubliceerde ... top-20 farmaceutische bedrijven zich de afgelopen twee jaar ... ontwikkelingslanden te verbeteren met nieuwe initiatieven, uitbreiding van ... blijven de prestaties achter.      (Photo: ... voert de Index voor de vierde keer aan. ...
Breaking Medicine Technology:HemoShear and Children's National Health System to Unveil New Paradigm for Accelerating Rare Disease Drug Discovery 2HemoShear and Children's National Health System to Unveil New Paradigm for Accelerating Rare Disease Drug Discovery 3HemoShear and Children's National Health System to Unveil New Paradigm for Accelerating Rare Disease Drug Discovery 4CTI BioPharma to Present at the Upcoming Investor Conferences 2Farmaceutische industrie doet meer om toegang tot medicijnen in ontwikkelingslanden te verbeteren; op een aantal punten blijven prestaties achter 2Farmaceutische industrie doet meer om toegang tot medicijnen in ontwikkelingslanden te verbeteren; op een aantal punten blijven prestaties achter 3Farmaceutische industrie doet meer om toegang tot medicijnen in ontwikkelingslanden te verbeteren; op een aantal punten blijven prestaties achter 4
... PHILADELPHIA, Nov. 29 Dr. Christine Cassel,expert and ... aging, has,been named a member of the Alzheimer,s ... by former Speaker of the House Newt Gingrich ... is President and Chief Executive Officer of the ...
... ... Clinton, Edwards, Obama and Kucinich support ending ban on federal funds ... for needle exchange, NEW YORK, Nov. 28 ... the,nation,s leading AIDS organizations -- polled 16 presidential hopefuls on,pressing AIDS-related issues as part of ...
Cached Medicine Technology:American Board of Internal Medicine President Named to Alzheimer's Study Group 2Leading AIDS Groups Turn Up The Heat on '08 Presidential Candidates 2Leading AIDS Groups Turn Up The Heat on '08 Presidential Candidates 3
(Date:11/18/2014)... A+ Secure Packaging, a leading ... supplements and more, announced today that its LaVergne ... Practices (GMP) Registration for dietary supplements and athletic ... International verifies the A+ Secure Packaging facility meets ... of its clients by demonstrating the proper methods, ...
(Date:11/18/2014)... Beach, CA (PRWEB) November 18, 2014 ... into new routines, many people look at fall as ... holidays. Dr. Kevin Sadati , Orange County facial ... this Newport Beach practice. At the Gallery of ... patients taking advantage of his non-invasive cosmetic surgery procedures. ...
(Date:11/18/2014)... Tara Haelle HealthDay Reporter ... of children who experience a severe abusive head trauma before ... according to a new study. In addition, among ... cut in half, the study found. Abusive head trauma ... is shaken and suffers head injuries, according to background information ...
(Date:11/18/2014)... Dennis Thompson ... News) -- Daily low-dose aspirin therapy may not have ... The study, which involved more than 14,000 ... difference in heart-related deaths or non-fatal heart attacks and ... didn,t. "It indicates that primary prevention with ...
(Date:11/18/2014)... Dennis Thompson HealthDay Reporter ... attack and stroke patients can safely take aspirin combined with ... combination won,t increase a patient,s risk of early death, according ... of the American Heart Association in Chicago. The report was ... Analysis of data from more than a dozen clinical ...
Breaking Medicine News(10 mins):Health News:A+ Secure Packaging, LLC Earns NSF International Good Manufacturing Practices (GMP) Registration for Dietary Supplements and Certification for Sport 2Health News:Orange County Facial Plastic Surgeon, Dr. Kevin Sadati Observes a New Trend of Non-invasive Cosmetic Surgery Procedures Becoming Increasingly Popular This Fall 2Health News:Orange County Facial Plastic Surgeon, Dr. Kevin Sadati Observes a New Trend of Non-invasive Cosmetic Surgery Procedures Becoming Increasingly Popular This Fall 3Health News:Head Trauma in Abused Babies, Toddlers Can Have Lifelong Impact 2Health News:Head Trauma in Abused Babies, Toddlers Can Have Lifelong Impact 3Health News:Head Trauma in Abused Babies, Toddlers Can Have Lifelong Impact 4Health News:Daily Aspirin Fails to Help Older Hearts in Japanese Study 2Health News:Daily Aspirin Fails to Help Older Hearts in Japanese Study 3Health News:Long-Term Use of Aspirin Plus Blood Thinner Is Safe: Study 2Health News:Long-Term Use of Aspirin Plus Blood Thinner Is Safe: Study 3
... among scientists and patients alike, about potential cures for diabetes, ... rectify the faulty insulin secreting pancreatic cells , blamed ... reducing the damage to the kidneys due to diabetes. ... can be used in humans to treat diabetes. ,The ...
... tough stride to ban child labour, a pervasive problem ... (Prohibition & Regulation) Act, 1986// was announced by the ... working as domestic servants, in dhabas, restaurants, resorts, and ... the plight of Child labour, a reality that screams ...
... of $2 million to Virginia Tech, even though he did ... ,His philanthropy is the result of a long-term ... he was a youngster, he used to mow the Torgersen's ... the Chairman and Chief Executive Officer of Google, and according ...
... In an effort to implement China's 'one dog' policy and check ... drive to crack down on illegal pet dogs from Nov 16. ... in Beijing and ensure that citizens have licence for their dogs, ... this year, China recorded 2,254 rabies cases, an increase of 29.69 ...
... deep-brain stimulation may improve the condition of patients ... involuntary muscle contractions resulting in repetitive movements. ... a thin wire carrying electric current is placed ... neurology at Christian-Albrechts University, said, 'It is a ...
... Epidemic, an acute infectious tropical disease, which started to ... 35 lives across //Pakistan especially from south province Sindh ... reported on Thursday that around 1,400 patients out of ... were admitted to hospitals across the country. Moreover 197 ...
Cached Medicine News:Health News:Let Us All Join Government To Ban Child Labour 2Health News:Once a Lawn Mower, a Self-made Billionaire Makes a Lasting Gift to Virginia Tech 2Health News:Once a Lawn Mower, a Self-made Billionaire Makes a Lasting Gift to Virginia Tech 3
Features four-way apron closure for super adjustability to fit staff of all shapes and sizes. Top left and right shoulder closures allow adjustment of armhole size and chest area of apron for close a...
Ties improve torso fit and transfer weight to waist and hips. Ties are 1"W cotton woven for flexibility and sewn at an angle across the full width of the two back sections for durability....
Ties improve torso fit and transfer weight to waist and hips. Ties are 1"W cotton woven for flexibility and sewn at an angle across the full width of the two back sections for durability....
Hip-hugging design transfers weight from shoulders to the hips. Crisscross shoulder design provides snug and comfortable upper torso fit while preventing apron from slipping off shoulders....
Medicine Products: